Bharat Biotech

Bharat Biotech FOUNDER –   Dr. Krishna M. Ella 

Business Story:

Founding: - Bharat Biotech International Limited was founded in 1996 by Dr. Krishna M. Ella, an entrepreneur and visionary in the field of biotechnology.

- Dr. Ella co-founded Bharat Biotech along with his wife, Suchitra Ella, who is also actively involved in the company's operations.

Initial Focus: - Bharat Biotech initially focused on developing novel vaccines and biotherapeutics.

- The company aimed to address unmet medical needs, particularly in the field of infectious diseases.

Research and Development: From its early days, Bharat Biotech invested significantly in research and development to create innovative and cost-effective solutions for various diseases.

Bharat Biotech achieved several milestones in the development of vaccines and biotherapeutics, gaining recognition for its contributions to public health.


Covaxin (COVID-19 Vaccine): - Bharat Biotech gained international attention for its role in developing Covaxin, an inactivated virus-based COVID-19 vaccine.

- Covaxin received emergency use authorization in India and was a significant part of the country's vaccination campaign.

Other Vaccines: In addition to Covaxin, Bharat Biotech has developed and marketed several other vaccines for diseases such as influenza, hepatitis, Japanese encephalitis, and typhoid.

Global Collaborations: Bharat Biotech has established collaborations and partnerships with various international organizations and research institutions to enhance its research capabilities and global reach.

Manufacturing Capacity: The company has invested in expanding its manufacturing capabilities to meet the increasing demand for its vaccines, both in India and globally.

Innovation and Commitment: Driven by a commitment to innovation and public health, Bharat Biotech continues to explore new avenues in biotechnology to develop solutions for emerging health challenges.

Worldwide Impact: Bharat Biotech's contributions extend beyond India, making a global impact through the development and distribution of vaccines that address critical health concerns.

- Dr. Krishna M. Ella's leadership and Bharat Biotech's commitment to research and development have positioned the company as a key player in the global biopharmaceutical industry. - The company's efforts in vaccine development, especially during the COVID-19 pandemic, have highlighted its dedication to public health on a global scale.